Initial Public Offering
Baird served as co-manager on this offering.
AboutPRA Health Sciences, Inc. (“PRA” or “the Company”) (NASDAQ-GS: PRAH) recently completed an initial public offering of 19,523,255 common shares at a price of $18.00 per share generating gross proceeds of approximately $351.4 million. The Company intends to use the net proceeds from the offering to redeem senior notes, repay borrowings and for general corporate purposes.
PRA is a global contract research organization providing outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company has therapeutic expertise in the largest areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. The Company is headquartered in Raleigh, North Carolina.
For additional information about this transaction, please contact:
- November 2014
- PRA Health Sciences, Inc.
- Target Location
- North America